biotechnology

• Will Health-Care ETFs Recover?

  By Staff Writer  |  March 1, 2009

  Despite their defensive nature, health-care stocks have been hospitalized, falling around 24 percent on average over the past year. The swift decline has created attractive...

• Lipper Says "Ouch" as Equity Funds Post Poor Returns

  By Janet Levaux, AdvisorOne  |  February 1, 2009

  Last year, equity funds posted their worst one-year return (-39.54 percent) in Lipper's database, which began in 1959, notes Tom Roseen, senior research analyst of...

• Biotech/Health Care

  By Janet Levaux, AdvisorOne  |  September 1, 2008

  Thanks to new drugs, acquisitions and other factors, biotech and health-care firms alike are forging beneficial growth and development strategies - which is good news...

• Healthy Entrance

  By Janet Levaux, AdvisorOne  |  March 1, 2008

  Stocks in health care, including biotech and pharmaceuticals, are poised for higher levels in 2008 - thanks to present valuations, developing pipelines and acquisition horizons,...

• The Great Index Quiz

  By Russell Wild  |  January 1, 2008

  Once Upon A Time...financial indices were delightfully simple constructions, designed to help measure movement in financial markets. There was the venerable S&P 500, the Dow,...

• Mapping the Index Universe

  By Staff Writer  |  December 1, 2007

  The rapid explosion of exchange-traded funds (ETFs) has been truly amazing to watch. With almost 600 U.S.-listed funds trading and over $500 billion in assets,...

• Early boomer retirement at 110

  By Staff Writer  |  March 1, 2007

  CNN recently reported on the findings of James Canton, a consultant on future trends to the likes of Motorola and the White House. Canton claims...

• VC the Hard Way

  By James Picerno  |  November 1, 2006

  "I spend 90 percent of my time on 5 percent of my clients' portfolios," says Dale Stevens, president of Grasswood Partners Inc., a Malibu, Calif....

• A Time of Innovation

  By Staff Writer  |  September 1, 2006

  New products and other factors drive growth in health care/biotech, despite a cautious regulatory environment, analysts say. ----- Jason Kantor RBC Capital Markets 415-633-8565 Jason.kantor@rbccm.com Outlook: Fundamentally, I don't think the...

• Small Packages

  By Britt Erica Tunick  |  April 1, 2006

  The smart money in 2006 is on small and micro cap stocks--at least that is the consensus among a large part of the investment community. Both...